APPLICATION
ANDA216510
TYPE
ANDA
ORIGINAL APPROVAL
2024-09-05
LATEST ACTION
2024-09-05
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
NELARABINEPrescription
NELARABINE 250MG/50ML (5MG/ML) · INJECTABLE · INTRAVENOUS
Approval history
2024-09-05UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.